Williams Gregory C. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Williams Gregory C.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-30+1,875→ 10,632 total - Tax Payment
Common Stock
2021-01-30$3.44/sh−643$2,212→ 9,989 total - Exercise/Conversion
Restricted Stock Units
2021-01-30−1,875→ 15,000 total→ Common Stock (1,875 underlying)
Footnotes (4)
- [F1]The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances.